Go Pro
→ Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown” (From Paradigm Press) (Ad)tc pixel Free CINGW Stock Alerts

Cingulate (CINGW) Competitors

$0.02 +0.00 (+1.83%)
As of 07/13/2026 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

CINGW vs. AIMDW, ALVOW, ACABW, BFRIW, and CELUW

Should you buy Cingulate stock or one of its competitors? MarketBeat compares Cingulate with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cingulate include Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

How does Cingulate compare to Ainos?

Cingulate (NASDAQ:CINGW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CingulateN/AN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

In the previous week, Ainos had 1 more articles in the media than Cingulate. MarketBeat recorded 2 mentions for Ainos and 1 mentions for Cingulate. Cingulate's average media sentiment score of 1.89 beat Ainos' score of 1.74 indicating that Cingulate is being referred to more favorably in the media.

Company Overall Sentiment
Cingulate Very Positive
Ainos Very Positive

Company Net Margins Return on Equity Return on Assets
CingulateN/A N/A N/A
Ainos N/A N/A N/A

Summary

Ainos beats Cingulate on 2 of the 3 factors compared between the two stocks.

How does Cingulate compare to Alvotech?

Cingulate (NASDAQ:CINGW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CingulateN/AN/AN/AN/AN/A
Alvotech$559.42MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
CingulateN/A N/A N/A
Alvotech N/A N/A N/A

In the previous week, Cingulate and Cingulate both had 1 articles in the media. Cingulate's average media sentiment score of 1.89 equaled Alvotech'saverage media sentiment score.

Company Overall Sentiment
Cingulate Very Positive
Alvotech Very Positive

Summary

Alvotech beats Cingulate on 1 of the 1 factors compared between the two stocks.

How does Cingulate compare to Atlantic Coastal Acquisition Corp. II?

Cingulate (NASDAQ:CINGW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CingulateN/AN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
CingulateN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

In the previous week, Cingulate had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Cingulate and 0 mentions for Atlantic Coastal Acquisition Corp. II. Cingulate's average media sentiment score of 1.89 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Cingulate is being referred to more favorably in the media.

Company Overall Sentiment
Cingulate Very Positive
Atlantic Coastal Acquisition Corp. II Neutral

Summary

Cingulate beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks.

How does Cingulate compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Cingulate (NASDAQ:CINGW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Cingulate N/A N/A N/A

In the previous week, Biofrontera and Biofrontera both had 1 articles in the media. Cingulate's average media sentiment score of 1.89 beat Biofrontera's score of 1.87 indicating that Cingulate is being referred to more favorably in the news media.

Company Overall Sentiment
Biofrontera Very Positive
Cingulate Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$43.20MN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

Summary

Biofrontera and Cingulate tied by winning 1 of the 2 factors compared between the two stocks.

How does Cingulate compare to Celularity?

Cingulate (NASDAQ:CINGW) and Celularity (NASDAQ:CELUW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
CingulateN/A N/A N/A
Celularity N/A N/A N/A

In the previous week, Cingulate and Cingulate both had 1 articles in the media. Cingulate's average media sentiment score of 1.89 equaled Celularity'saverage media sentiment score.

Company Overall Sentiment
Cingulate Very Positive
Celularity Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CingulateN/AN/AN/AN/AN/A
Celularity$26.55MN/AN/AN/AN/A

Summary

Celularity beats Cingulate on 1 of the 1 factors compared between the two stocks.

Get Cingulate News Delivered to You Automatically

Sign up to receive the latest news and ratings for CINGW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CINGW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CINGW vs. The Competition

Export
MetricCingulateBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$510.06M$7.05B$12.61B
Dividend YieldN/A3.90%2.68%8.00%
P/E RatioN/A3.1627.1124.26
Price / SalesN/A6,474.90589.18117.88
Price / CashN/A13.1329.2249.36
Price / BookN/A85.6710.736.29
Net IncomeN/A-$96.07M$3.58B$330.66M
7 Day PerformanceN/A-0.96%-2.11%-1.35%
1 Month PerformanceN/A2.45%3.27%-0.64%
1 Year PerformanceN/A59.98%26.32%19.08%

Cingulate Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CINGW
Cingulate
N/A$0.02
+6.9%		N/A-41.8%$0.00N/AN/A20
AIMDW
Ainos
N/A$0.15
-1.4%		N/A+23.5%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.17
-0.1%		N/AN/A$0.00$559.42MN/A4
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15
BFRIW
Biofrontera
N/A$0.03
-18.0%		N/A-73.2%$0.00$43.20MN/A70

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:CINGW) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
BNZI Lands a Zacks Upgrade!
Banzai International (NASDAQ: BNZI) just received a Zacks Rank 2 (Buy) upgrade, driven by improving earnings e...
Huge Alerts | Sponsoredtc pixel
American’s Biggest Threat Is Here
This feels like one of those ''where were you when Kennedy was shot'' moments. It felt like a moment in time, ...
Goldco Direct, LLC | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Under $1 while the market panics
The new deadline for crypto’s best bill, the Clarity Act, is August 7th. That's the Senate's final session day...
Crypto 101 Media | Sponsoredtc pixel